What is headache? Explain types and cure in details

Reading File
Finding Sources
Finding Sources
Searching the Web

headache types classification treatment 2024 guidelines

Reading File
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive, rich information from multiple authoritative textbooks. Let me compile a thorough response.

Headache: Definition, Types & Treatment


What Is a Headache?

Headache (cephalalgia) is pain or discomfort in the region of the cranial vault — encompassing aches arising from the scalp, meningeal arteries, dural sinuses, falx cerebri, and proximal segments of large pial arteries. Importantly, much of the brain parenchyma itself, ventricular ependyma, choroid plexus, and pial veins are not pain-sensitive.
Pain arises via the trigeminovascular system: the trigeminal nerve innervates intracranial vessels and dura mater, and signals are relayed through the trigeminocervical complex (caudal trigeminal nucleus + upper cervical spinal cord) to the thalamus and cortex. Autonomic symptoms (tearing, nasal congestion, ptosis) reflect cranial parasympathetic pathway activation — they are secondary, not causative.
"Migraine is a brain disorder and is best understood and managed as such." — Harrison's Principles of Internal Medicine, 22e

Classification: Primary vs. Secondary

The International Headache Society (IHS) ICHD-3 divides all headaches into two major groups:
CategoryDescriptionPrevalence
PrimaryNo underlying structural cause; headache IS the disease~90% of all headaches
SecondaryCaused by an identifiable underlying condition~10%

Primary Headache Prevalence (Harrison's):

Type% of Primary Headaches
Tension-type69%
Migraine16%
Idiopathic stabbing2%
Exertional1%
Cluster0.1%

Secondary Headache Causes:

Cause%
Systemic infection63%
Head injury4%
Vascular disorders1%
Subarachnoid hemorrhage<1%
Brain tumor0.1%

PRIMARY HEADACHES IN DETAIL


1. Tension-Type Headache (TTH)

The most common headache overall — affecting ~75% of people at some point.
Features:
  • Location: Always bilateral, band-like or pressing sensation around the head
  • Quality: Dull, steady, non-throbbing, non-pulsating
  • Severity: Mild to moderate; does not incapacitate
  • Duration: 30 minutes to several hours (episodic) or continuous (chronic)
  • No nausea, vomiting, photophobia, or phonophobia (distinguishes it from migraine)
  • Chronic TTH: occurs >15 days/month; associated with depression and posttraumatic headache
"Tension-type headache…not primarily caused by muscle tension or stress" — Neuroanatomy through Clinical Cases, 3e
Treatment:
  • Acute: NSAIDs (ibuprofen, naproxen), acetaminophen, aspirin
  • Non-pharmacologic: Muscle relaxation, biofeedback, regular sleep, stress management
  • Chronic/preventive: Tricyclic antidepressants (amitriptyline), lifestyle modification, physical therapy

2. Migraine

Affects ~16% of all headache sufferers; more common in women (3:1 ratio).
Features:
  • Location: Unilateral in 2/3 of attacks; can be bilateral
  • Quality: Pulsating/throbbing
  • Severity: Moderate to severe; often incapacitating
  • Duration: 4–72 hours
  • Associated symptoms: Nausea, vomiting, photophobia, phonophobia, osmophobia
  • Clinical mnemonic (93% PPV): Presence of 2/3 of: Photosensitivity, Incapacitation, Nausea = migraine diagnosis
Subtypes:
  • Migraine without aura — most common form
  • Migraine with aura — preceded by reversible neurologic symptoms (visual zigzag scintillations, scotoma, sensory changes) lasting 20–30 min
  • Chronic migraine — headache on ≥15 days/month
  • Status migrainosus — severe migraine lasting >72 hours
  • Hemiplegic migraine — rare; unilateral motor weakness as aura; linked to calcium channel gene mutations (CACNA1A)
  • Retinal migraine — transient monocular visual loss without headache
  • Vestibular migraine — dizziness/vertigo with migrainous features
Triggers: Menstruation, alcohol (red wine), sleep disruption, stress, certain foods (chocolate, aged cheese, smoked meats), bright light, caffeine changes.
Treatment:
ApproachAgents
Mild-moderate acuteNSAIDs, acetaminophen, aspirin + caffeine, antiemetics (metoclopramide, prochlorperazine)
Moderate-severe acuteTriptans (sumatriptan, zolmitriptan, rizatriptan) — 5-HT₁B/D agonists; Ergotamine/dihydroergotamine
Newer acute agentsDitans (lasmiditan — 5-HT₁F agonist); Gepants (ubrogepant, rimegepant — CGRP antagonists)
Preventive (prophylactic)Beta-blockers (propranolol, metoprolol), calcium channel blockers (verapamil), anticonvulsants (topiramate, valproate), tricyclic antidepressants (amitriptyline), CGRP monoclonal antibodies (erenumab, fremanezumab)
Refractory/chronicBotulinum toxin type A (Botox) injections — if ≥3 preventive agents failed; greater occipital nerve block
Non-pharmacologicRest in dark quiet room, cold compresses, hydration, avoiding triggers, regular sleep schedule, biofeedback

3. Cluster Headache

Relatively rare (~0.1% of headaches) but extraordinarily severe — one of the most painful conditions known.
Features:
  • Demographics: Predominantly adult men (age 20–50); male:female ≈ 5:1
  • Location: Strictly unilateral — severe, boring/stabbing pain deep behind one eye
  • Quality: Non-throbbing, excruciating — often described as a "hot poker in the eye"
  • Duration: 15–180 minutes per attack (usually 30–90 min)
  • Pattern: Attacks occur 1–8 times/day in "clusters" lasting weeks to months, followed by remission periods of months to years
  • Autonomic features (ipsilateral): Lacrimation, conjunctival injection, ptosis, miosis (partial Horner's syndrome), nasal congestion/rhinorrhea, facial flushing, forehead sweating
  • Functional neuroimaging shows posterior hypothalamic activation during attacks
  • Classified as a Trigeminal Autonomic Cephalalgia (TAC)
Treatment:
ApproachAgents
Acute abort100% oxygen inhalation (7–12 L/min × 15 min — highly effective and unique to cluster); Sumatriptan SC or nasal spray; Zolmitriptan nasal spray
Preventive (bridge)Short course of prednisone or ergotamine during cluster period
Preventive (maintenance)Verapamil (first-line), lithium, topiramate, valproate
RefractoryOccipital nerve stimulation; sphenopalatine ganglion stimulation

4. Other Primary Headache Types

TypeKey FeaturesTreatment
Paroxysmal hemicraniaLike cluster but shorter attacks (2–30 min), more frequent, more common in womenIndomethacin (virtually diagnostic response)
Hemicrania continuaUnilateral continuous headache with autonomic featuresIndomethacin
SUNCT/SUNAShort-lasting unilateral neuralgiform headache with conjunctival injection/tearing (seconds to minutes)Lamotrigine, IV lidocaine
Thunderclap headache"Worst headache of life," instantaneous onsetEmergency evaluation — rule out subarachnoid hemorrhage first (CT/LP)
Cough/exertional headacheTriggered by Valsalva, exercise, sexual activityIndomethacin; rule out posterior fossa lesion
Hypnic headacheWakes patient from sleep, usually elderlyCaffeine, lithium, indomethacin
New daily persistent headacheAbrupt onset, continuous from day oneTreat as migraine or TTH

SECONDARY HEADACHES — Key Causes to Recognize

Red Flags ("SNOOP4" Mnemonic):

FlagConcern
Systemic symptoms (fever, weight loss)Meningitis, temporal arteritis, malignancy
Neurologic deficitsMass lesion, stroke
Onset sudden/thunderclapSubarachnoid hemorrhage
Older age (new headache >50)Giant cell arteritis, tumor
Pattern changeProgressive disease
Postural changeIntracranial hypertension/CSF leak
PapilledemaRaised intracranial pressure
Precipitated by ValsalvaPosterior fossa lesion

Important Secondary Causes:

  • Subarachnoid hemorrhage: Thunderclap headache — emergent CT, then lumbar puncture if CT negative
  • Meningitis: Headache + fever + neck stiffness + photophobia — LP essential
  • Temporal (giant cell) arteritis: Temporal headache + jaw claudication + elevated ESR in patients >50 years → start prednisone 80 mg/day immediately before biopsy to prevent blindness
  • Idiopathic intracranial hypertension (pseudotumor cerebri): Obese young women, positional headache, papilledema, pulsatile tinnitus → treat with acetazolamide, weight loss; LP as therapy
  • Medication overuse headache (MOH): Paradoxical daily headache from overuse of acute headache medications (>10–15 days/month) — treat by withdrawing the offending agent + preventive therapy
  • Post-traumatic headache: Most common symptom after mild TBI; treat symptomatically; image only if high-risk features

Summary: Distinguishing the Big Three

FeatureTension-typeMigraineCluster
LocationBilateralUnilateral (often)Unilateral (always)
QualityPressing/tighteningThrobbing/pulsatingBoring/stabbing
SeverityMild–moderateModerate–severeSevere–excruciating
Duration30 min – days4–72 hours15–180 min
Nausea/vomitingNoYesRarely
PhotophobiaNoYesNo
Autonomic featuresNoSometimesYes (hallmark)
Movement aggravationNoYesRestlessness/agitation
Gender predominanceEqualFemale (3:1)Male (5:1)
Acute treatmentNSAIDsTriptansO₂, sumatriptan SC
PreventiveAmitriptylineBeta-blockers, topiramate, CGRP MAbsVerapamil

Sources:
  • Harrison's Principles of Internal Medicine, 22e, Ch. 17 & 441
  • Adams and Victor's Principles of Neurology, 12e, Ch. 9
  • Neuroanatomy through Clinical Cases, 3e, Table 5.2
  • Tintinalli's Emergency Medicine, 9e
  • ICHD-3, International Headache Society
This is a shared conversation. Sign in to Orris to start your own chat.